Analyst Ratings for Rigel Pharmaceuticals (RIGL) [Buys]

RIGL Rating Summary

RIGL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RIGL
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $7.67 (+233.3%) * Over Last 12-Mos
Rating Score: 4 / 10   Percentile Rank: 40%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/13/2016 Piper Jaffray New Coverage Overweight
(N/A)
10.00
(N/A)
2.39 2.30 -3.77% Details
4/22/2016 JPMorgan Upgrade Overweight
(Neutral)
5.00
(N/A)
2.49 2.30 -7.63% Details